Paydirt
Insider filing · MIRM

Peter Radovich sold $272K of Mirum Pharmaceuticals (MIRM)

Executed Feb 2, disclosed Feb 3, 1 day later.

Value, as filed
$272K
2,631 sh × $103.30
Executed
Feb 2
the trade date, as filed
Disclosed
Feb 3
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
purchases only

Returns are measured on stock purchases only.

The filer
PR Peter Radovich PRESIDENT AND COO profile →

Peter Radovich (PRESIDENT AND COO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $1.5M of MIRM (16,515 sh × $91.98, as filed), executed Mar 16.

The name
MIRM Mirum Pharmaceuticals, Inc. MIRM · Healthcare · 60 filings in 24 months ticker →

Healthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…

More Healthcare filings Insider filings, newest first View the original filing at www.sec.gov
Other filings by Peter Radovich in MIRM
MIRMSALE Mirum Pharmaceuticals, Inc. $1.5M
16,515 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $302K
3,143 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $222K
2,382 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $348K
7,879 sh × $44.21
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $623K
13,681 sh × $45.57
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $127K
2,627 sh × $48.22
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. $152K
3,177 sh × $47.92
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET